Related Experiment Video
Updated: Aug 15, 2026

10:28
Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
Published on: February 18, 2016
Clinical aspects of phencyclidine (PCP)
The International Journal of the Addictions
|January 1, 1987
Summary
This review covers phencyclidine (PCP) abuse, detailing its history, effects, diagnosis, and treatment options based on current literature. It offers a comprehensive overview for understanding and managing PCP-related issues.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Phencyclidine (PCP) is a dissociative anesthetic with a history of recreational abuse.
- PCP abuse presents significant challenges in clinical diagnosis and management.
- Understanding the multifaceted nature of PCP is crucial for effective intervention.
Purpose of the Study:
- To conduct a comprehensive review of the existing phencyclidine literature.
- To explore the historical context, clinical manifestations, diagnostic standards, and therapeutic strategies for PCP abuse.
- To synthesize current knowledge on PCP for researchers and clinicians.
Main Methods:
- Literature review methodology.
- Systematic search of scientific databases for phencyclidine-related studies.
- Analysis and synthesis of 71 cited references.
Main Results:
- Detailed historical overview of phencyclidine's emergence and use.
- Elucidation of the diverse clinical effects associated with PCP intoxication.
- Summary of established diagnostic criteria for PCP abuse and dependence.
- Overview of current treatment modalities and approaches for PCP-related disorders.
Conclusions:
- Phencyclidine abuse remains a significant public health concern requiring ongoing research and clinical attention.
- A thorough understanding of PCP's history, effects, diagnosis, and treatment is essential for healthcare professionals.
- This review consolidates key information to guide future research and clinical practice in managing PCP abuse.
Related Concept Videos
CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Personality Disorders: Paranoid and Schizoid
Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...
Paranoid Personality Disorder
Paranoid personality disorder is...

